Substance / Medication

Terbutaline sulfate

Overview

Clinical overview including description, indications, and evidence base is pending physician authorship or FDA SPL integration. Graph-derived relationship data is available below.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

Clinical Trials

352 trials linked to this intervention

352
Total Trials
40
Recruiting
114
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Fast-dissolving sublingual films of terbutaline sulfate: formulation and in vitro/in vivo evaluation.
Sayed Soha, Ibrahim Howida Kamal, Mohamed Magdy Ibrahim et al. · Mol Pharm · 2013
PMID: 23883311RCT
Determination of terbutaline sulfate and its degradation products in pharmaceutical formulations using LC.
Daraghmeh N, Al-Omari M M, Sara Z et al. · J Pharm Biomed Anal · 2002
PMID: 12093527Observational
Focal Seizures in a Child Receiving Terbutaline Sulfate: A Case Report.
Nadeem Falah, Ali Maria, Hameed Nida · Cureus · 2023
PMID: 37719479Case ReportFull text (PMC)
Acute paraparesis due to terbutaline sulfate.
Herskowitz Allan, Herskowitz Brad · South Med J · 2002
PMID: 11846262Case Report
[Local necrosis of finger following stab with needle used to pump terbutaline sulfate (Bricalin)].
Yasin M, Vishne T H, Hendel D · Harefuah · 2001
PMID: 11419060Case Report
Development and Validation of an HPLC Method for Impurity Profiling in Terbutaline Sulfate Oral Syrup.
Yang Renming, Zeng Qin, Yang Likai et al. · J Chromatogr Sci · 2025
PMID: 41459988Other

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Health Goals

Goals connected through associated conditions

Quick Facts

Type
Substance / Medication
Fully Specified Name
Terbutaline sulfate (substance)
SNOMED CT
24583009
UMLS CUI
C0039543

Clinical Data

This intervention maps to 7 entities in the Healos knowledge graph.

1
Conditions
3
Biomarkers
2
Specialists
0
Symptoms
352
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.

Terbutaline sulfate — Conditions, Biomarkers & Specialists | Healos | Healos